CRO Pharmaceutical Product Development (PPD) has added Bhooshi De Silva as senior vice president of corporate development and strategy to its executive leadership team. De Silva will focus on key strategic initiatives vital to supporting PPD’s growth and client success, including corporate development, strategy and mergers and acquisitions.
With 15 years of experience in the biopharmaceutical industry, De Silva started his career at Pfizer, holding roles across the R&D and commercial organizations in portfolio management, strategy and operations. His responsibilities included overseeing the development and strengthening of analytical frameworks and decision-making processes.
In 2009, De Silva was named vice president of business development evaluation and strategy, leading a team in the evaluation of licensing, acquisitions and corporate strategic initiatives for Pfizer. Most recently, he was head of business development, corporate strategy and international teams at Optimer Pharmaceuticals.